SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Buy and Sell Signals, and Other Market Perspectives
SPY 689.17+0.2%Dec 11 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Katelew who wrote (144930)5/6/2020 11:25:01 AM
From: codfish2311 Recommendations

Recommended By
Bob Miller
Brian Sullivan
GROUND ZERO™
Hawkmoon
isopatch

and 6 more members

  Read Replies (4) of 220068
 
The prolonged QT interval nonsense was an excuse to not approve its use, not a reason.

The hundreds of thousands of Americans taking Plaquenil (hydroxychloroquine) for their RA and Psoriatic arthritis are not monitored in any way. To not approve its use in this circumstance, especially after it was shown to be effective against CV in 2005, IMHO just shows how corrupt the system is.

They're tossing out a regimen that could save thousands of lives, and costs virtually nothing, in order to potentially save a few from side effects. Ridiculous.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News